Pregnancy and reproduction in autoimmune rheumatic diseases

Monika Østensen, Antonio Brucato, Howard Carp, Christina Chambers, Radboud J E M Dolhain, Andrea Doria, Frauke Förger, Caroline Gordon, Sinuhe Hahn, Munther Khamashta, Michael D. Lockshin, Marco Matucci-Cerinic, Pierluigi Meroni, J. Lee Nelson, Ann Parke, Michelle Petri, Luigi Raio, Guillermo Ruiz-Irastorza, Clovis A. Silva, Angela Tincani & 3 others Peter M. Villiger, Dorothea Wunder, Maurizio Cutolo

Research output: Contribution to journalArticle

Abstract

Despite evidence for the important role of oestrogens in the aetiology and pathophysiology of chronic immune/inflammatory diseases, the previous view of an unequivocal beneficial effect of oestrogens on RA compared with a detrimental effect on SLE has to be reconsidered. Likewise, the long-held belief that RA remits in the majority of pregnant patients has been challenged, and shows that only half of the patients experience significant improvement when objective disease activity measurements are applied. Pregnancies in patients with SLE are mostly successful when well planned and monitored interdisciplinarily, whereas a small proportion of women with APS still have adverse pregnancy outcomes in spite of the standard treatment. New prospective studies indicate better outcomes for pregnancies in women with rare diseases such as SSc and vasculitis. Fertility problems are not uncommon in patients with rheumatic disease and need to be considered in both genders. Necessary therapy, shortly before or during the pregnancy, demands taking into account the health of both mother and fetus. Long-term effects of drugs on offspring exposed in utero or during lactation is a new area under study as well as late effects of maternal rheumatic disease on children.

Original languageEnglish (US)
Article numberkeq350
Pages (from-to)657-664
Number of pages8
JournalRheumatology
Volume50
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Rheumatic Diseases
Autoimmune Diseases
Reproduction
Pregnancy
Pregnancy Outcome
Estrogens
Mothers
Immune System Diseases
Rare Diseases
Vasculitis
Lactation
Fertility
Fetus
Prospective Studies
Health
Therapeutics
Pharmaceutical Preparations

Keywords

  • Antiphospholipid syndrome
  • Fertility
  • Neonatal lupus
  • Oestrogen
  • Pre-eclampsia
  • Pregnancy
  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Systemic sclerosis
  • Vasculitis

ASJC Scopus subject areas

  • Rheumatology
  • Pharmacology (medical)

Cite this

Østensen, M., Brucato, A., Carp, H., Chambers, C., Dolhain, R. J. E. M., Doria, A., ... Cutolo, M. (2011). Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology, 50(4), 657-664. [keq350]. https://doi.org/10.1093/rheumatology/keq350

Pregnancy and reproduction in autoimmune rheumatic diseases. / Østensen, Monika; Brucato, Antonio; Carp, Howard; Chambers, Christina; Dolhain, Radboud J E M; Doria, Andrea; Förger, Frauke; Gordon, Caroline; Hahn, Sinuhe; Khamashta, Munther; Lockshin, Michael D.; Matucci-Cerinic, Marco; Meroni, Pierluigi; Nelson, J. Lee; Parke, Ann; Petri, Michelle; Raio, Luigi; Ruiz-Irastorza, Guillermo; Silva, Clovis A.; Tincani, Angela; Villiger, Peter M.; Wunder, Dorothea; Cutolo, Maurizio.

In: Rheumatology, Vol. 50, No. 4, keq350, 04.2011, p. 657-664.

Research output: Contribution to journalArticle

Østensen, M, Brucato, A, Carp, H, Chambers, C, Dolhain, RJEM, Doria, A, Förger, F, Gordon, C, Hahn, S, Khamashta, M, Lockshin, MD, Matucci-Cerinic, M, Meroni, P, Nelson, JL, Parke, A, Petri, M, Raio, L, Ruiz-Irastorza, G, Silva, CA, Tincani, A, Villiger, PM, Wunder, D & Cutolo, M 2011, 'Pregnancy and reproduction in autoimmune rheumatic diseases', Rheumatology, vol. 50, no. 4, keq350, pp. 657-664. https://doi.org/10.1093/rheumatology/keq350
Østensen M, Brucato A, Carp H, Chambers C, Dolhain RJEM, Doria A et al. Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology. 2011 Apr;50(4):657-664. keq350. https://doi.org/10.1093/rheumatology/keq350
Østensen, Monika ; Brucato, Antonio ; Carp, Howard ; Chambers, Christina ; Dolhain, Radboud J E M ; Doria, Andrea ; Förger, Frauke ; Gordon, Caroline ; Hahn, Sinuhe ; Khamashta, Munther ; Lockshin, Michael D. ; Matucci-Cerinic, Marco ; Meroni, Pierluigi ; Nelson, J. Lee ; Parke, Ann ; Petri, Michelle ; Raio, Luigi ; Ruiz-Irastorza, Guillermo ; Silva, Clovis A. ; Tincani, Angela ; Villiger, Peter M. ; Wunder, Dorothea ; Cutolo, Maurizio. / Pregnancy and reproduction in autoimmune rheumatic diseases. In: Rheumatology. 2011 ; Vol. 50, No. 4. pp. 657-664.
@article{90ebeb8acab743ebbedbd672b8295b97,
title = "Pregnancy and reproduction in autoimmune rheumatic diseases",
abstract = "Despite evidence for the important role of oestrogens in the aetiology and pathophysiology of chronic immune/inflammatory diseases, the previous view of an unequivocal beneficial effect of oestrogens on RA compared with a detrimental effect on SLE has to be reconsidered. Likewise, the long-held belief that RA remits in the majority of pregnant patients has been challenged, and shows that only half of the patients experience significant improvement when objective disease activity measurements are applied. Pregnancies in patients with SLE are mostly successful when well planned and monitored interdisciplinarily, whereas a small proportion of women with APS still have adverse pregnancy outcomes in spite of the standard treatment. New prospective studies indicate better outcomes for pregnancies in women with rare diseases such as SSc and vasculitis. Fertility problems are not uncommon in patients with rheumatic disease and need to be considered in both genders. Necessary therapy, shortly before or during the pregnancy, demands taking into account the health of both mother and fetus. Long-term effects of drugs on offspring exposed in utero or during lactation is a new area under study as well as late effects of maternal rheumatic disease on children.",
keywords = "Antiphospholipid syndrome, Fertility, Neonatal lupus, Oestrogen, Pre-eclampsia, Pregnancy, Rheumatoid arthritis, Systemic lupus erythematosus, Systemic sclerosis, Vasculitis",
author = "Monika {\O}stensen and Antonio Brucato and Howard Carp and Christina Chambers and Dolhain, {Radboud J E M} and Andrea Doria and Frauke F{\"o}rger and Caroline Gordon and Sinuhe Hahn and Munther Khamashta and Lockshin, {Michael D.} and Marco Matucci-Cerinic and Pierluigi Meroni and Nelson, {J. Lee} and Ann Parke and Michelle Petri and Luigi Raio and Guillermo Ruiz-Irastorza and Silva, {Clovis A.} and Angela Tincani and Villiger, {Peter M.} and Dorothea Wunder and Maurizio Cutolo",
year = "2011",
month = "4",
doi = "10.1093/rheumatology/keq350",
language = "English (US)",
volume = "50",
pages = "657--664",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Pregnancy and reproduction in autoimmune rheumatic diseases

AU - Østensen, Monika

AU - Brucato, Antonio

AU - Carp, Howard

AU - Chambers, Christina

AU - Dolhain, Radboud J E M

AU - Doria, Andrea

AU - Förger, Frauke

AU - Gordon, Caroline

AU - Hahn, Sinuhe

AU - Khamashta, Munther

AU - Lockshin, Michael D.

AU - Matucci-Cerinic, Marco

AU - Meroni, Pierluigi

AU - Nelson, J. Lee

AU - Parke, Ann

AU - Petri, Michelle

AU - Raio, Luigi

AU - Ruiz-Irastorza, Guillermo

AU - Silva, Clovis A.

AU - Tincani, Angela

AU - Villiger, Peter M.

AU - Wunder, Dorothea

AU - Cutolo, Maurizio

PY - 2011/4

Y1 - 2011/4

N2 - Despite evidence for the important role of oestrogens in the aetiology and pathophysiology of chronic immune/inflammatory diseases, the previous view of an unequivocal beneficial effect of oestrogens on RA compared with a detrimental effect on SLE has to be reconsidered. Likewise, the long-held belief that RA remits in the majority of pregnant patients has been challenged, and shows that only half of the patients experience significant improvement when objective disease activity measurements are applied. Pregnancies in patients with SLE are mostly successful when well planned and monitored interdisciplinarily, whereas a small proportion of women with APS still have adverse pregnancy outcomes in spite of the standard treatment. New prospective studies indicate better outcomes for pregnancies in women with rare diseases such as SSc and vasculitis. Fertility problems are not uncommon in patients with rheumatic disease and need to be considered in both genders. Necessary therapy, shortly before or during the pregnancy, demands taking into account the health of both mother and fetus. Long-term effects of drugs on offspring exposed in utero or during lactation is a new area under study as well as late effects of maternal rheumatic disease on children.

AB - Despite evidence for the important role of oestrogens in the aetiology and pathophysiology of chronic immune/inflammatory diseases, the previous view of an unequivocal beneficial effect of oestrogens on RA compared with a detrimental effect on SLE has to be reconsidered. Likewise, the long-held belief that RA remits in the majority of pregnant patients has been challenged, and shows that only half of the patients experience significant improvement when objective disease activity measurements are applied. Pregnancies in patients with SLE are mostly successful when well planned and monitored interdisciplinarily, whereas a small proportion of women with APS still have adverse pregnancy outcomes in spite of the standard treatment. New prospective studies indicate better outcomes for pregnancies in women with rare diseases such as SSc and vasculitis. Fertility problems are not uncommon in patients with rheumatic disease and need to be considered in both genders. Necessary therapy, shortly before or during the pregnancy, demands taking into account the health of both mother and fetus. Long-term effects of drugs on offspring exposed in utero or during lactation is a new area under study as well as late effects of maternal rheumatic disease on children.

KW - Antiphospholipid syndrome

KW - Fertility

KW - Neonatal lupus

KW - Oestrogen

KW - Pre-eclampsia

KW - Pregnancy

KW - Rheumatoid arthritis

KW - Systemic lupus erythematosus

KW - Systemic sclerosis

KW - Vasculitis

UR - http://www.scopus.com/inward/record.url?scp=79952783034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952783034&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/keq350

DO - 10.1093/rheumatology/keq350

M3 - Article

VL - 50

SP - 657

EP - 664

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 4

M1 - keq350

ER -